Global Computational Biology Market Research Report 2023

Publication ID:

PB504236554

Publication Date:

April 10, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

Computational biology involves the development and application of data-analytical and theoretical methods, mathematical modeling and computational simulation techniques to the study of biological, ecological, behavioral and social systems.
Highlights
The global Computational Biology market was valued at US$ 2456.1 million in 2022 and is anticipated to reach US$ 4613.7 million by 2029, witnessing a CAGR of 11.1% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Computational biology is different from biological computing, which is a subfield of computer science and computer engineering using bioengineering and biology to build computers, but is similar to bioinformatics, which is an interdisciplinary science using computers to store and process biological data.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Computational Biology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Computational Biology.
The Computational Biology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Computational Biology market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Computational Biology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Chemical Computing
Accelrys
Certara
Compugen
Entelos
Insilico Biotechnology
Genedata
Leadscope
Simulation Plus
Schrodinger
Rhenovia Pharma
Nimbus Discovery
Segment by Type
In-House
Contract
Segment by Application
Cellular & Biological Simulation
Pharmacogenomics
Drug Discovery
Drug Development
Lead Optimization
Lead Discovery
Pharmacokinetics
Disease Modeling
Clinical Trials
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Computational Biology companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Computational Biology Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 In-House
1.2.3 Contract
1.3 Market by Application
1.3.1 Global Computational Biology Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Cellular & Biological Simulation
1.3.3 Pharmacogenomics
1.3.4 Drug Discovery
1.3.5 Drug Development
1.3.6 Lead Optimization
1.3.7 Lead Discovery
1.3.8 Pharmacokinetics
1.3.9 Disease Modeling
1.3.10 Clinical Trials
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Computational Biology Market Perspective (2018-2029)
2.2 Computational Biology Growth Trends by Region
2.2.1 Global Computational Biology Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Computational Biology Historic Market Size by Region (2018-2023)
2.2.3 Computational Biology Forecasted Market Size by Region (2024-2029)
2.3 Computational Biology Market Dynamics
2.3.1 Computational Biology Industry Trends
2.3.2 Computational Biology Market Drivers
2.3.3 Computational Biology Market Challenges
2.3.4 Computational Biology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Computational Biology Players by Revenue
3.1.1 Global Top Computational Biology Players by Revenue (2018-2023)
3.1.2 Global Computational Biology Revenue Market Share by Players (2018-2023)
3.2 Global Computational Biology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Computational Biology Revenue
3.4 Global Computational Biology Market Concentration Ratio
3.4.1 Global Computational Biology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Computational Biology Revenue in 2022
3.5 Computational Biology Key Players Head office and Area Served
3.6 Key Players Computational Biology Product Solution and Service
3.7 Date of Enter into Computational Biology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Computational Biology Breakdown Data by Type
4.1 Global Computational Biology Historic Market Size by Type (2018-2023)
4.2 Global Computational Biology Forecasted Market Size by Type (2024-2029)
5 Computational Biology Breakdown Data by Application
5.1 Global Computational Biology Historic Market Size by Application (2018-2023)
5.2 Global Computational Biology Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Computational Biology Market Size (2018-2029)
6.2 North America Computational Biology Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Computational Biology Market Size by Country (2018-2023)
6.4 North America Computational Biology Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Computational Biology Market Size (2018-2029)
7.2 Europe Computational Biology Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Computational Biology Market Size by Country (2018-2023)
7.4 Europe Computational Biology Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Computational Biology Market Size (2018-2029)
8.2 Asia-Pacific Computational Biology Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Computational Biology Market Size by Region (2018-2023)
8.4 Asia-Pacific Computational Biology Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Computational Biology Market Size (2018-2029)
9.2 Latin America Computational Biology Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Computational Biology Market Size by Country (2018-2023)
9.4 Latin America Computational Biology Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Computational Biology Market Size (2018-2029)
10.2 Middle East & Africa Computational Biology Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Computational Biology Market Size by Country (2018-2023)
10.4 Middle East & Africa Computational Biology Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Chemical Computing
11.1.1 Chemical Computing Company Detail
11.1.2 Chemical Computing Business Overview
11.1.3 Chemical Computing Computational Biology Introduction
11.1.4 Chemical Computing Revenue in Computational Biology Business (2018-2023)
11.1.5 Chemical Computing Recent Development
11.2 Accelrys
11.2.1 Accelrys Company Detail
11.2.2 Accelrys Business Overview
11.2.3 Accelrys Computational Biology Introduction
11.2.4 Accelrys Revenue in Computational Biology Business (2018-2023)
11.2.5 Accelrys Recent Development
11.3 Certara
11.3.1 Certara Company Detail
11.3.2 Certara Business Overview
11.3.3 Certara Computational Biology Introduction
11.3.4 Certara Revenue in Computational Biology Business (2018-2023)
11.3.5 Certara Recent Development
11.4 Compugen
11.4.1 Compugen Company Detail
11.4.2 Compugen Business Overview
11.4.3 Compugen Computational Biology Introduction
11.4.4 Compugen Revenue in Computational Biology Business (2018-2023)
11.4.5 Compugen Recent Development
11.5 Entelos
11.5.1 Entelos Company Detail
11.5.2 Entelos Business Overview
11.5.3 Entelos Computational Biology Introduction
11.5.4 Entelos Revenue in Computational Biology Business (2018-2023)
11.5.5 Entelos Recent Development
11.6 Insilico Biotechnology
11.6.1 Insilico Biotechnology Company Detail
11.6.2 Insilico Biotechnology Business Overview
11.6.3 Insilico Biotechnology Computational Biology Introduction
11.6.4 Insilico Biotechnology Revenue in Computational Biology Business (2018-2023)
11.6.5 Insilico Biotechnology Recent Development
11.7 Genedata
11.7.1 Genedata Company Detail
11.7.2 Genedata Business Overview
11.7.3 Genedata Computational Biology Introduction
11.7.4 Genedata Revenue in Computational Biology Business (2018-2023)
11.7.5 Genedata Recent Development
11.8 Leadscope
11.8.1 Leadscope Company Detail
11.8.2 Leadscope Business Overview
11.8.3 Leadscope Computational Biology Introduction
11.8.4 Leadscope Revenue in Computational Biology Business (2018-2023)
11.8.5 Leadscope Recent Development
11.9 Simulation Plus
11.9.1 Simulation Plus Company Detail
11.9.2 Simulation Plus Business Overview
11.9.3 Simulation Plus Computational Biology Introduction
11.9.4 Simulation Plus Revenue in Computational Biology Business (2018-2023)
11.9.5 Simulation Plus Recent Development
11.10 Schrodinger
11.10.1 Schrodinger Company Detail
11.10.2 Schrodinger Business Overview
11.10.3 Schrodinger Computational Biology Introduction
11.10.4 Schrodinger Revenue in Computational Biology Business (2018-2023)
11.10.5 Schrodinger Recent Development
11.11 Rhenovia Pharma
11.11.1 Rhenovia Pharma Company Detail
11.11.2 Rhenovia Pharma Business Overview
11.11.3 Rhenovia Pharma Computational Biology Introduction
11.11.4 Rhenovia Pharma Revenue in Computational Biology Business (2018-2023)
11.11.5 Rhenovia Pharma Recent Development
11.12 Nimbus Discovery
11.12.1 Nimbus Discovery Company Detail
11.12.2 Nimbus Discovery Business Overview
11.12.3 Nimbus Discovery Computational Biology Introduction
11.12.4 Nimbus Discovery Revenue in Computational Biology Business (2018-2023)
11.12.5 Nimbus Discovery Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Chemical Computing
Accelrys
Certara
Compugen
Entelos
Insilico Biotechnology
Genedata
Leadscope
Simulation Plus
Schrodinger
Rhenovia Pharma
Nimbus Discovery

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂